Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Mersana Therapeutics Q4 EPS $(0.68) Misses $(0.67) Estimate

Mersana Therapeutics (NASDAQ:MRSN) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.67) by 1.49 percent. This is a 61.9 percent decrease over losses of $(0.42) per share
byBenzinga Newsdesk
February 28, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Mersana Therapeutics (NASDAQ:MRSN) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.67) by 1.49 percent. This is a 61.9 percent decrease over losses of $(0.42) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts